Stock listing

TPEx:6879 Tci Gene Inc. (大江基因) 股價

Follow Tci Gene Inc. into a list and get an email when it puts out news.

Share price · TPEX:6879

$31.55 TWD -2.85 (-8.3%)

Close on Nov 20, 2026

This year -15.2% · daily closes, Dec 1, 2025 – Nov 20, 2026, adjusted for splits
Day range
$31.35 – $32.50 TWDNov 20, 2026
Volume
5,345 sharesNov 20, 2026
Market cap
$834.8M TWDAt the close on Nov 20, 2026 · price × 26.46M shares outstanding
Traded on an average day
$82,549 TWDMedian day 12 shares · 6 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Tci Gene Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6879 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$31.55-2.85-8.3%$31.85$32.50$31.355,345
$34.40-0.10-0.3%$34.40$34.40$34.4011
$34.500.000.0%$34.50$34.50$34.500
$34.50-1.00-2.8%$34.20$34.50$34.205,800
$35.500.000.0%$35.50$35.50$35.5010
$35.500.000.0%$35.50$35.50$35.501
$35.500.000.0%$35.50$35.50$35.5010
$35.50-0.25-0.7%$34.50$35.50$34.502,010
$35.75+1.10+3.2%$34.65$35.75$34.0015,100
$34.65-1.65-4.5%$34.50$34.65$32.4022,837
$36.300.000.0%$36.30$36.30$36.156,020
$36.30+0.30+0.8%$34.50$36.30$34.507,020
$36.000.000.0%$36.00$36.00$36.0074
$36.000.000.0%$36.00$36.00$36.0010
$36.000.000.0%$34.65$36.00$34.5010,010
$36.000.000.0%$36.00$36.00$36.0010
$36.00-0.45-1.2%$36.45$36.45$34.854,431
$36.450.000.0%$36.45$36.45$36.4510
$36.450.000.0%$36.45$36.45$36.450
$36.450.000.0%$36.45$36.45$36.4510
$36.45+0.15+0.4%$36.45$36.45$36.4510
$36.30+0.10+0.3%$36.30$36.30$36.3010
$36.200.000.0%$36.20$36.20$36.203
$36.200.000.0%$36.20$36.20$34.70913
$36.20-0.30-0.8%$36.50$36.50$34.706,426
$36.50-0.20-0.5%$35.00$36.50$34.903,520
$36.700.000.0%$36.70$36.70$36.7010
$36.700.000.0%$36.70$36.70$36.7012
$36.70+0.10+0.3%$36.70$36.70$36.703
$36.60+0.25+0.7%$36.60$36.60$36.6043
$36.350.000.0%$36.35$36.35$36.352,000
$36.35+1.65+4.8%$34.70$36.35$34.705,020
$34.700.000.0%$34.70$34.70$34.7010
$34.700.000.0%$34.70$34.70$34.7010
$34.70-0.80-2.3%$34.10$34.70$34.104,016
$35.500.000.0%$34.10$35.50$34.101,010
$35.500.000.0%$35.50$35.50$35.502
$35.50+0.50+1.4%$35.00$35.50$35.003,010
$35.000.000.0%$35.00$35.00$35.002
$35.00-0.80-2.2%$35.80$35.80$34.409,030
$35.800.000.0%$34.20$35.80$34.204,164
$35.800.000.0%$35.80$35.80$35.8010
$35.800.000.0%$34.20$35.80$34.2055
$35.800.000.0%$35.80$35.80$35.8020
$35.800.000.0%$35.80$35.80$35.80410
$35.80-1.20-3.2%$36.55$36.55$34.758,140
$37.00+0.70+1.9%$35.40$37.00$35.405,020
$36.30+0.75+2.1%$35.55$36.30$34.504,280
$35.550.000.0%$35.55$35.55$35.551,010
$35.550.000.0%$33.80$35.55$33.801,236
$35.550.000.0%$35.55$35.55$35.5510
$35.550.000.0%$35.55$35.55$35.5510
$35.550.000.0%$35.55$35.55$35.5510
$35.550.000.0%$35.55$35.55$35.550
$35.550.000.0%$35.55$35.55$35.5510
$35.550.000.0%$35.55$35.55$35.5510
$35.550.000.0%$35.55$35.55$35.550
$35.550.000.0%$35.55$35.55$35.5510
$35.550.000.0%$35.55$35.55$35.5510
$35.55+1.55+4.6%$34.00$35.55$33.006,050
$34.000.000.0%$34.00$34.00$34.000
$34.000.000.0%$34.00$34.00$34.000
Ticker
TPEx:6879
Asset type
Stock
Exchange
TPEx
Currency
TWD

Latest news

All Tci Gene Inc. news

Tci Gene Inc. on 6ix

News releases
25 in all · newest Jul 21, 2022 · oldest 2022

Valuation

Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
−$24.60M TWD
P/E
20.6×
EV/sales
−0.1×
EV/EBITDA
−0.8×
Price/book
0.9×
Gross margin
55.8%
Operating margin
7.0%
Net margin
14.8%
Debt to equity
0.0×
Beta
No index for this market yet

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Revenue273.6M347.5M333.9M424.0M432.2M
Cost of revenue121.0M143.5M159.2M180.7M192.8M
Gross profit152.6M204.1M174.6M243.4M239.4M
Research and development33.7M34.1M45.6M62.3M59.5M
Selling, general and administrative99.8M114.2M123.0M89.9M66.4M
Operating income19.1M55.8M6.02M91.1M113.6M
Depreciation and amortization12.0M13.8M15.9M29.6M37.8M
EBITDA31.1M69.6M22.0M120.7M151.4M
Interest expense1.40M495.0K1.18M852.0K835.0K
Income before tax39.0M67.6M8.78M90.1M116.4M
Net income40.6M56.3M11.7M72.1M92.5M
Earnings per share, basic1.532.130.442.733.49

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents250.7M98.4M696.0M932.7M326.2M
Short-term investments581.0M738.5M203.6M5.00M4.00M
Receivables44.0M95.7M102.6M71.6M116.9M
Inventory18.8M43.9M54.8M57.0M31.2M
Current assets914.3M994.3M1.07B1.08B486.3M
Total assets1.01B1.10B1.17B1.16B560.3M
Accounts payable25.1M39.8M75.3M59.9M71.3M
Current liabilities98.6M101.3M155.5M143.2M169.4M
Total liabilities98.6M101.3M155.5M143.2M169.4M
Shareholders' equity890.5M974.7M986.5M1.01B380.2M
Shares outstanding26.5M26.5M26.5M26.5M26.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations151.3M57.0M17.8M110.4M119.2M
Capital spending-417.0K-2.66M-3.17M-15.3M-23.4M
Free cash flow150.9M54.3M14.7M95.1M95.8M
Dividends paid-52.9M-26.5M-52.9M-53.6M
Change in cash152.3M-597.6M-236.7M606.6M148.6M

Open Financials

Cap table

Built by 6ix from Tci Gene Inc.’s releases

Common shares
26,458,520
Fully diluted
26,458,520

Fully diluted

LineShares
Common shares26,458,520

Share count over time

CountShares
Nov 22, 202626,458,520

Open Cap table

Shareholders

HolderSharesOf the companyAs of
大江生醫股份有限公司11.2M42.2%Oct 31, 2026
佳世達科技股份有限公司4.72M17.8%Oct 31, 2026
林詠翔732K2.8%Oct 31, 2026
陳敬亭50,0000.19%Oct 31, 2026
林竣緯00.00%Oct 31, 2026
Counde O'Yang00.00%Oct 31, 2026
林水永00.00%Oct 31, 2026
楊宏培00.00%Oct 31, 2026
孫維新00.00%Oct 31, 2026
張可盈00.00%Oct 31, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about Tci Gene Inc.